Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Q3 2025 Management View Guillermo Novo, Chairman & CEO, highlighted the completion of portfolio optimization and stated, “We ...

Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the ...

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

Novocure's Tumor Treating Fields tech offers promise in oncology. NVCR trades at a compelling valuation after the recent ...

EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, today announced results for its third quarter ended June 30, 2025.

AstraZeneca’s CEO said the company has proposed U.S. price cuts to some drugs, while Doximity enters competitive AI scribing ...

China trade talks wrap up, Berkshire’s potential railroad deal, oil prices spike, and more news to start your day.

Investors braced for the Federal Reserve's next interest rate decision and earnings from tech giants Microsoft and Meta.

The Kentucky-based company’s results are a bright spot in what’s otherwise been a gloomy quarter for health insurers. Humana ...